This trial is evaluating whether Exercise will improve 1 primary outcome, 11 secondary outcomes, and 1 other outcome in patients with Coronary Disease. Measurement will happen over the course of from baseline to week-6 and from baseline to week-12.
This trial requires 172 total participants across 2 different treatment groups
This trial involves 2 different treatments. Exercise is the primary treatment being studied. Participants will be divided into 2 treatment groups. There is no placebo group. The treatments being tested are not being studied for commercial purposes.
Cardiovascular disease may manifest as acute, non-specific chest pain, dizziness, fatigue, breathlessness, feeling short of air, palpitations, paleness, chest discomfort, feeling fainting, heart palpitations, headaches, high blood pressure, or a slow pulse. More serious symptoms include angina, aneurysm, a heart attack (acute coronary syndrome), or a heart block.
The majority of people who undergo primary CAVB will receive no adverse consequences. The main challenge for patients undergoing this elective procedure is that the risk of future problems increases during the immediate post-operative period. Thus, we have a choice between accepting the inherent risks or seeking alternative treatment options.
Coronary artery disease (CAD) is the leading cause of death in the western world. Many risk factors are known, but it is still unclear how these factors affect the extent of coronary artery disease. This paper focuses on some factors which may increase the risk of coronary artery disease in the general population. At present the main clinical risks for coronary artery disease are high blood pressure.
The most common treatment for CHD (and also for angioplasty) is percutaneous coronary interventions (PCI). For patients who undergo PCI, this is followed by coronary artery bypass graft surgery (CABG). A significant number of patients require concomitant interventions of the two major procedures.
In the United States, around 12.2 million adults have at least one major cardiac event each year. This makes up 4.9% of all American adults.
[Coronary artery disease (CAD) is an inflammatory disease of the wall of the arteries that supply oxygen and nutrients to the heart muscle. It is also the leading cause of deaths around the world. The disease starts with the buildup of plaque, which in turn leads to coronary artery atherosclerosis, which then leads to coronary artery disease.(https://eMedicine.com)] It can be prevented with diet changes and exercise. One of the benefits of exercise is to raise one's heart rate, which helps flush out the plaque from the coronary arteries. As I said in the title of this article, heart-related diseases are among the most serious because they put an irreversible limit on one's life expectancy.
Patients have a good understanding of the benefits of clinical trials. However, they will not always consider clinical trials if they are not aware of their high risk. Therefore, when patients must decide about receiving clinical trials, it is important to make them aware of their high risk of complications. One option is that patients should be asked to choose from several clinical trials. Patients must also be made aware that clinical trials are not a cure, and that patients will continue to be monitored even after participation.
Currently, the majority of clinical research seems to focus on developing a more effective and longer lasting method than conventional exercise for the rehabilitation of patients with CAD.
Results from a recent paper suggest that hereditary factors are at least as important as environmental ones in determining a positive family history of CAD.
Data from a recent study suggest that the average age of onset for coronary disease increases during the age interval from 40 to 85 years. These data suggest the need for early screening of coronary risk factors in this age range.
Although the overall prevalence of atherosclerosis increased with age, age alone was not a potent predictor of clinically significant disease. Although atherosclerotic disease was more commonly found in men than in women, the two groups had similar risks and survival. This was particularly true for myocardial disease. Atherosclerotic disease occurred in men and women with coronary disease at similar rates. Thus we believe that coronary disease, in both men and women, is more probably a multifactorial disorder.
In addition to an increased risk of death from accidents and cardiac disease, excessive exercise results in a host of systemic health issues which can include fatigue and other musculoskeletal discomfort.